Literature DB >> 21267702

Chondroid chordoma of the skull base: immunohistochemical and ultrastructural study of two cases with special reference to microtubules within rough-surfaced endoplasmic reticulum.

Masayuki Shintaku1, Kenichiro Maeno, Hidetoshi Okabe.   

Abstract

Two cases of skull base chordoma (case 1, a 57-year-old woman; case 2, a 69-year-old woman) were investigated immunohistochemically and ultrastructurally. The tumors showed histopathological features typical of chondroid chordoma and contained both classical chordomatous and hyaline cartilaginous components. Tumor cells were immunoreactive for cytokeratin, vimentin, and S-100 protein, but negative for microtubule-associated protein 2 and class III beta-tubulin (tub-B3). Tumor cells of case 2 were immunoreactive for tau-protein and class II beta-tubulin (tub-B2), whereas those of case 1 were negative. Ultrastructurally, tumor cells in both cases showed the presence of abundant glycogen granules, well-developed intracellular organelles, and desmosome-like junctions. In case 2, several microtubules were closely packed and ran parallel or in random directions within the dilated cisterns of rough-surfaced endoplasmic reticulum (rough ER). "Microtubules within rough ER" has been described in several neoplasms, including classical and chondroid chordomas. Although previous reports documented the tub-B3 immunoreactivity in chordomas, our results suggested that, in our case 2, the predominant isoform of beta-tubulin in microtubules within rough ER was not tub-B3 but tub-B2.

Entities:  

Mesh:

Year:  2011        PMID: 21267702     DOI: 10.1007/s00795-010-0509-0

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  19 in total

1.  Immunohistochemical distribution of tubulin beta II in human normal and neoplastic tissues.

Authors:  Eriko Oda; Yasuhiro Nakamura; Munehiko Yamamoto; Masamichi Kojiro
Journal:  Kurume Med J       Date:  2005

Review 2.  Structure and utilization of tubulin isotypes.

Authors:  K F Sullivan
Journal:  Annu Rev Cell Biol       Date:  1988

Review 3.  Extraskeletal myxoid chondrosarcoma: updated clinicopathological and molecular genetic characteristics.

Authors:  Masanori Hisaoka; Hiroshi Hashimoto
Journal:  Pathol Int       Date:  2005-08       Impact factor: 2.534

4.  Identification of conserved isotype-defining variable region sequences for four vertebrate beta tubulin polypeptide classes.

Authors:  K F Sullivan; D W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

5.  Microtubular aggregates within rough endoplasmic reticulum in myxopapillary ependymoma of the filum terminale.

Authors:  K L Ho
Journal:  Arch Pathol Lab Med       Date:  1990-09       Impact factor: 5.534

6.  Expression of tau proteins and tubulin in extraskeletal myxoid chondrosarcoma, chordoma, and other chondroid tumors.

Authors:  B Hu; L McPhaul; M Cornford; K Gaal; J Mirra; S W French
Journal:  Am J Clin Pathol       Date:  1999-08       Impact factor: 2.493

7.  Microtubular aggregates in the rough endoplasmic reticulum of sacrococcygeal chordoma.

Authors:  Y Ueda; I Nakanishi; H Tsuchiya; K Tomita
Journal:  Ultrastruct Pathol       Date:  1991 Jan-Feb       Impact factor: 1.094

8.  Microtubule aggregates in a clival chordoma.

Authors:  P B Jeffrey; R L Davis; C Biava; M Rosenblum
Journal:  Arch Pathol Lab Med       Date:  1993-10       Impact factor: 5.534

9.  Chondroid chordoma.

Authors:  G W Mierau; D A Weeks
Journal:  Ultrastruct Pathol       Date:  1987       Impact factor: 1.094

10.  Chondroid chordoma. Electron-microscopic study of two cases.

Authors:  E Valderrama; L B Kahn; S Lipper; J Marc
Journal:  Am J Surg Pathol       Date:  1983-10       Impact factor: 6.394

View more
  1 in total

Review 1.  Skull base chondroid chordoma: atypical case manifesting as intratumoral hemorrhage and literature review.

Authors:  Satoshi Tsutsumi; Chihiro Akiba; Takamoto Suzuki; Hajime Nakanishi; Hiroshi Izumi; Yukimasa Yasumoto; Masanori Ito
Journal:  Clin Neuroradiol       Date:  2014-07-29       Impact factor: 3.649

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.